Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 4
2(50.0%)
4Total
N/A(2)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT07553832Not Yet Recruiting

Clinical and Subclinical Keratoconus Cohort Study

Role: collaborator

NCT03653156Recruiting

China Cognition and Aging Study

Role: collaborator

NCT03657732Recruiting

The Chinese Familial Alzheimer's Network

Role: collaborator

NCT02660411Not ApplicableCompleted

Impact of Anesthesia Maintenance Methods on Long-term Survival

Role: collaborator

NCT02662257Not ApplicableCompleted

Impact of Anesthesia Maintenance Methods on Incidence of Postoperative Delirium

Role: collaborator

NCT03057691Unknown

The Impact of Depression and/or Anxiety on PCI Patients

Role: collaborator

NCT02241590Phase 4Unknown

Treatment of Liver Cirrhosis Due to Hepatitis B Virus With Fuzheng Huayu and Entecavir

Role: collaborator

NCT02241616Phase 4Unknown

Traditional Chinese Medicine Combined With Entecavir to Treat Refractory Liver Fibrosis in Liver Cirrhosis Due to HBV

Role: collaborator

All 8 trials loaded